Thursday, December 9, 2010

How Did Dendreon Commercialize the First Ever Cancer Vaccine?

This is your last chance to take advantage of early bird pricing and save $500 off the Vaccine Business Congress event!

With the vaccine industry booming and profits continuing to rise, having the tools to secure your next deal is imperative. The Vaccine Business Congress is the only place where you will hear firsthand how innovators secured lucrative deals in the vaccine space.

Our gripping keynote presentations are the first of their kind:
-Thomas Monath gives an in-depth analysis on where the industry is headed with the integration of large biotechs in the big Pharma machine.
-Greg Schiffman discusses for the first time how Dendreon raised a billion dollars on its own to commercialize Provenge – the first ever cancer vaccine.

Download the brochure to find out more about the Vaccine Business Congress taking place March 2-4, 2011 in Baltimore:

Aloycia Bellillie our Attendance Project Manager, handle all inquiries and registrations and is delighted to work with you to explore potential conference savings opportunities, including early registration or group discounts. Please make sure to reach out to her directly to register, either by phone: 646-895-7410 or email: to ensure best pricing.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment